Taysha Gene Therapies, Inc. (TSHA) Dividend Yield, History & Forecast
Taysha Gene Therapies, Inc. (TSHA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. market capitalization is approximately $1.09B.
Frequently Asked Questions about Taysha Gene Therapies, Inc. (TSHA)
Is Taysha Gene Therapies, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Taysha Gene Therapies, Inc. in?▾
Taysha Gene Therapies, Inc. (TSHA) operates in the Healthcare sector, specifically the Biotechnology industry.
